Literature DB >> 27449037

Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.

Kai Guo1, Shaobo Zheng1, Yawen Xu1, Abai Xu1, Binshen Chen1, Yong Wen2.   

Abstract

The biological role of miR-26a involved in the carcinogenesis of prostate cancer (PC) has been controversial. Besides, the underlying mechanism by which miR-26a plays a role in PC has been unclear. To investigate the role of miR-26a-5p in the PC, miR-26a-5p was detected and statistically analyzed in clinical PC tissues and a panel of PC cell lines. Using bioinformatics analysis, we found that serpine1 messenger RNA (mRNA) binding protein 1 (SERBP1) was a potential downstream target of miR-26a-5p. Using luciferase reporter and western blot, we identified that miR-26a-5p negatively regulated SERBP1 on the PC cell line level. It was confirmed that miR-26a-5p was markedly downregulated in PC tissues compared with normal controls whose reduced expression was significantly associated with metastasis and poor overall prognosis and found that miR-26a-5p was able to prevent proliferation and motility of PC cells in vitro. Additionally, SERBP1 was identified as a downstream target of miR-26a-5p. Moreover, it was observed that SERBP1 was markedly upregulated in prostate cancer tissues and was significantly associated with tissue metastasis and Gleason score. Taken together, our results for the first time demonstrate that the loss of miR-26a-5p promotes proliferation, migration, and invasion through targeting SERBP1 in PC, supporting the tumor-suppressing role of miR-26a-5p in PC.

Entities:  

Keywords:  Metastasis; Prognosis; Proliferation; Prostate cancer; SERBP1; miR-26a-5p

Mesh:

Substances:

Year:  2016        PMID: 27449037     DOI: 10.1007/s13277-016-5158-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

1.  Selected isomiR expression profiles via arm switching?

Authors:  Li Guo; Hui Zhang; Yang Zhao; Sheng Yang; Feng Chen
Journal:  Gene       Date:  2013-10-11       Impact factor: 3.688

2.  Expression profile analysis reveals putative prostate cancer-related microRNAs.

Authors:  H Song; Y Liu; J Pan; S T Zhao
Journal:  Genet Mol Res       Date:  2013-10-24

3.  Reproducibility crisis: Blame it on the antibodies.

Authors:  Monya Baker
Journal:  Nature       Date:  2015-05-21       Impact factor: 49.962

4.  SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex.

Authors:  Yelenis Mari; Graham M West; Catherina Scharager-Tapia; Bruce D Pascal; Ruben D Garcia-Ordonez; Patrick R Griffin
Journal:  J Proteome Res       Date:  2015-10-07       Impact factor: 4.466

Review 5.  Evolution of treatment options for patients with CRPC and bone metastases: bone-targeted agents that go beyond palliation of symptoms to improve overall survival.

Authors:  Kyle O Rove; E David Crawford
Journal:  Oncology (Williston Park)       Date:  2011-12       Impact factor: 2.990

6.  Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.

Authors:  Dominique Koensgen; Alexander Mustea; Irina Klaman; Pengming Sun; Menelaos Zafrakas; Werner Lichtenegger; Carsten Denkert; Edgar Dahl; Jalid Sehouli
Journal:  Gynecol Oncol       Date:  2007-08-14       Impact factor: 5.482

7.  MiR-26a inhibits prostate cancer progression by repression of Wnt5a.

Authors:  Shijia Zhao; Xiangdong Ye; Lei Xiao; Xuexiong Lian; Yupeng Feng; Feng Li; Li Li
Journal:  Tumour Biol       Date:  2014-06-28

8.  miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer.

Authors:  Min Deng; Hai-lin Tang; Xi-hong Lu; Mei-yuan Liu; Xiao-min Lu; Yi-xue Gu; Ji-fang Liu; Zhi-min He
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

9.  miR-339-3p inhibits proliferation and metastasis of colorectal cancer.

Authors:  Chang Zhou; Yenxia Lu; Xuenong Li
Journal:  Oncol Lett       Date:  2015-09-02       Impact factor: 2.967

10.  miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2.

Authors:  Li Yu; Juan Lu; Bao Zhang; Xiong Liu; Lu Wang; Si-Yang Li; Xiao-Hong Peng; Xia Xu; Wen-Dong Tian; Xiang-Ping Li
Journal:  Oncol Lett       Date:  2013-02-04       Impact factor: 2.967

View more
  15 in total

1.  miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC.

Authors:  L Chang; K Li; T Guo
Journal:  Clin Transl Oncol       Date:  2016-11-18       Impact factor: 3.405

2.  Overexpression of Nucleolin and Associated Genes in Prostate Cancer.

Authors:  Virginie Firlej; Pascale Soyeux; Maya Nourieh; Eric Huet; Fannie Semprez; Yves Allory; Arturo Londono-Vallejo; Alexandre de la Taille; Francis Vacherot; Damien Destouches
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells.

Authors:  Kati Erdmann; Knut Kaulke; Christiane Rieger; Karsten Salomo; Manfred P Wirth; Susanne Fuessel
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-25       Impact factor: 4.553

4.  Identification and Characterization of MicroRNAs in the Goat (Capra hircus) Rumen during Embryonic Development.

Authors:  Tao Zhong; Jiangtao Hu; Ping Xiao; Siyuan Zhan; Linjie Wang; Jiazhong Guo; Li Li; Hongping Zhang; Lili Niu
Journal:  Front Genet       Date:  2017-10-26       Impact factor: 4.599

5.  Discovering the miR-26a-5p Targetome in Prostate Cancer Cells.

Authors:  Milena Rizzo; Gabriele Berti; Francesco Russo; Sofia Fazio; Monica Evangelista; Romina D'Aurizio; Marco Pellegrini; Giuseppe Rainaldi
Journal:  J Cancer       Date:  2017-08-22       Impact factor: 4.207

Review 6.  The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.

Authors:  Chun-Jiao Song; Huan Chen; Li-Zhong Chen; Guo-Mei Ru; Jian-Jun Guo; Qian-Nan Ding
Journal:  J Cell Biochem       Date:  2017-12-04       Impact factor: 4.429

7.  miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.

Authors:  Ping Wang; Long Lv
Journal:  Oncotarget       Date:  2016-12-06

8.  LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p/TRPC3 pathway.

Authors:  Jun Gao; Kang Zeng; Yi Liu; Lin Gao; Lishi Liu
Journal:  Onco Targets Ther       Date:  2018-12-24       Impact factor: 4.147

Review 9.  Complex interactomes and post-translational modifications of the regulatory proteins HABP4 and SERBP1 suggest pleiotropic cellular functions.

Authors:  Carolina Colleti; Talita Diniz Melo-Hanchuk; Flávia Regina Moraes da Silva; Ângela Saito; Jörg Kobarg
Journal:  World J Biol Chem       Date:  2019-11-21

10.  The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.

Authors:  Adam Kosti; Patricia Rosa de Araujo; Wei-Qing Li; Gabriela D A Guardia; Jennifer Chiou; Caihong Yi; Debashish Ray; Fabiana Meliso; Yi-Ming Li; Talia Delambre; Mei Qiao; Suzanne S Burns; Franziska K Lorbeer; Fanny Georgi; Markus Flosbach; Sarah Klinnert; Anne Jenseit; Xiufen Lei; Carolina Romero Sandoval; Kevin Ha; Hong Zheng; Renu Pandey; Aleksandra Gruslova; Yogesh K Gupta; Andrew Brenner; Erzsebet Kokovay; Timothy R Hughes; Quaid D Morris; Pedro A F Galante; Stefano Tiziani; Luiz O F Penalva
Journal:  Genome Biol       Date:  2020-08-06       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.